1973
DOI: 10.3181/00379727-142-36963
|View full text |Cite
|
Sign up to set email alerts
|

Studies on the Protective Effect of Diphenylhydantoin Against Alloxan Diabetes in Mice

Abstract: An earlier communication from these laboratories described the protective effect of diphenylhydantoin (DPH) against the diabetogenic action of alloxan in mice ( l ) . The intraperitoneal injection of from 10 to 45 mg/kg of DPH, one hour prior to the intravenous injection of alloxan, prevents pancreatic beta cell necrosis and the development of chronic hyperglycemia.Although the mechanism through which alloxan produces its pancreotoxic effect remains obscure, certain structural requirements have been recognized… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

1976
1976
1976
1976

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 3 publications
(4 reference statements)
0
2
0
Order By: Relevance
“…The structural similarities between alloxan, barbituric acid, tolbutamide and diphenylhydantoin have led to an earlier suggestion that the observed interactions may be reflections of competition for binding sites on the pancreatic B-cell membrane [1,4]. All of these chemicals possess unsubstituted ureido groups in their structural configurations and the importance of this portion of the molecules of alloxan and diphenylhydantoin have been shown in earlier in vivo experiments [4,10].…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…The structural similarities between alloxan, barbituric acid, tolbutamide and diphenylhydantoin have led to an earlier suggestion that the observed interactions may be reflections of competition for binding sites on the pancreatic B-cell membrane [1,4]. All of these chemicals possess unsubstituted ureido groups in their structural configurations and the importance of this portion of the molecules of alloxan and diphenylhydantoin have been shown in earlier in vivo experiments [4,10].…”
Section: Discussionmentioning
confidence: 97%
“…The demonstration of the in vivo interactions between DPH, alloxan and tolbutamide has led to the hypothesis that these agents compete for binding sites on the pancreatic B-cell membrane [4]. Evidence in support of this hypothesis, however, is indirect and does not rule out the possible role of the known membrane stabilizing action of DPH.…”
mentioning
confidence: 99%